140 related articles for article (PubMed ID: 9786468)
1. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 1998 Sep; 42(3):297-301. PubMed ID: 9786468
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.
Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 1997 May; 41(5):1196-202. PubMed ID: 9145901
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.
Malathum K; Coque TM; Singh KV; Murray BE
Antimicrob Agents Chemother; 1999 Apr; 43(4):930-6. PubMed ID: 10103202
[TBL] [Abstract][Full Text] [Related]
4. Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status.
Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 1998 Jun; 41(6):649-53. PubMed ID: 9687104
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004.
Jamjian C; Biedenbach DJ; Jones RN
Antimicrob Agents Chemother; 1997 Feb; 41(2):454-9. PubMed ID: 9021207
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of RU-66647, a new ketolide.
Jones RN; Biedenbach DJ
Diagn Microbiol Infect Dis; 1997; 27(1-2):7-12. PubMed ID: 9127099
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.
Reinert RR; Bryskier A; Lütticken R
Antimicrob Agents Chemother; 1998 Jun; 42(6):1509-11. PubMed ID: 9624505
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.
Denis A; Agouridas C; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N; Pejac JM; Perron S
Bioorg Med Chem Lett; 1999 Nov; 9(21):3075-80. PubMed ID: 10560728
[TBL] [Abstract][Full Text] [Related]
9. The bactericidal activities of HMR 3004, HMR 3647 and erythromycin against gram-positive bacilli and development of resistance.
Fernández-Roblas R; Calvo R; Esteban J; Bryskier A; Soriano F
J Antimicrob Chemother; 1999 Feb; 43(2):285-9. PubMed ID: 11252337
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae.
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 1998 Aug; 42(8):2138-40. PubMed ID: 9687424
[TBL] [Abstract][Full Text] [Related]
11. Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae.
Rospide MF; Biedenbach DJ; Jones RN
Int J Antimicrob Agents; 2001 Jun; 17(6):451-5. PubMed ID: 11397614
[TBL] [Abstract][Full Text] [Related]
12. In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens.
Soriano F; Fernández-Roblas R; Calvo R; García-Calvo G; Pardeiro M; Bryskier A
J Antimicrob Chemother; 1998 Nov; 42(5):647-9. PubMed ID: 9848450
[TBL] [Abstract][Full Text] [Related]
13. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.
Boswell FJ; Andrews JM; Ashby JP; Fogarty C; Brenwald NP; Wise R
J Antimicrob Chemother; 1998 Dec; 42(6):703-9. PubMed ID: 10052892
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates.
Zarazaga M; Sáenz Y; Portillo A; Tenorio C; Ruiz-Larrea F; Del Campo R; Baquero F; Torres C
Antimicrob Agents Chemother; 1999 Dec; 43(12):3039-41. PubMed ID: 10582908
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of the new ketolide HMR3647 in comparison with those of macrolides and pristinamycins against Enterococcus spp.
Torres C; Zarazaga M; Tenorio C; Portillo A; Saenz Y; Ruiz F; Baquero F
Antimicrob Agents Chemother; 1998 Dec; 42(12):3279-81. PubMed ID: 9835527
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials.
Soriano F; Fernández-Roblas R; Calvo R; García-Calvo G
Antimicrob Agents Chemother; 1998 May; 42(5):1028-33. PubMed ID: 9593121
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.
Jalava J; Kataja J; Seppälä H; Huovinen P
Antimicrob Agents Chemother; 2001 Mar; 45(3):789-93. PubMed ID: 11181362
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci.
Singh KV; Malathum K; Murray BE
Antimicrob Agents Chemother; 2001 Dec; 45(12):3640-3. PubMed ID: 11709359
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria.
Martínez-Martínez L; Pascual A; Suárez AI; Perea EJ
Antimicrob Agents Chemother; 1998 Dec; 42(12):3290-2. PubMed ID: 9835530
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
Rolston KV; LeBlanc B; Ho DH
J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
